Compare EPM & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPM | ORMP |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.2M | 117.8M |
| IPO Year | 1996 | N/A |
| Metric | EPM | ORMP |
|---|---|---|
| Price | $3.66 | $3.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.93 | N/A |
| AVG Volume (30 Days) | ★ 593.4K | 177.9K |
| Earning Date | 02-10-2026 | 11-13-2025 |
| Dividend Yield | ★ 13.52% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $85,232,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.22 | N/A |
| P/E Ratio | ★ N/A | $3.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.19 | $1.82 |
| 52 Week High | $5.70 | $3.67 |
| Indicator | EPM | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 74.64 |
| Support Level | $3.19 | $3.32 |
| Resistance Level | $3.42 | $3.54 |
| Average True Range (ATR) | 0.13 | 0.20 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 87.74 | 96.74 |
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.